Background: Many patients with bone metastases whose diagnoses came only after they had suffered aggravated conditions are still frequently encountered. However, there have been few studies regarding the early diagnosis of such metastases. We retrospectively reviewed the clinical courses of cases we experienced between 2004 and 2014 to clarify the practical situation of diagnosis of such bone metastases.
Introduction
The incidence of cancer worldwide increased by 33% between 2005 and 2015, with population aging as the major contributing factor 1 . In Japan, with one of the world's most advanced aging populations, the incidence of cancer is steadily increasing and is about to reach 1 million per year 2 . The presence or absence of bone metastasis is indispensable information for accurate staging and appropriate treatment of the primary malignancy. In addition, when progressing, bone metastasis causes various skeletal-related events, leading to significant losses both in clinical outcomes and costs 3 . Recently, treatments of bone metastasis have been changing dramatically with the development of molecular targeting drugs and bone modifying agents 4 . Still, we encounter many patients whose diagnoses of bone metastases come only after they suffer aggravated conditions after long treatment under other diagnoses. Early diagnosis of bone metastasis is essential to prevent such aggravated conditions.
Patients under treatment or observation for known cancer are routinely evaluated with bone scintigraphy, computed tomography (CT), or blood examination for bone metastasis. On the other hand, patients with bone metastasis without any history of malignancy must be distinguished from among many elderly patients with other common orthopedic diseases. The incidence of bone metastasis from unknown malignancy may be as high as 30% 5 the early diagnosis of such bone metastasis so far. It has not yet been clarified whether is it possible to make a diagnosis of bone metastasis in patients without a history of malignancy at the first visit to a clinic, or if not, how long it may take to make the diagnosis, nor what specific factors are important for making the diagnosis. To clarify these questions, we retrospectively reviewed the clinical courses of our cases regarding diagnosis at the first visit, diagnostic process, and skeletal-related events at diagnosis.
Materials and Methods
This study was approved by our institutional review boards and was conducted in accordance with the Declaration of Helsinki. A retrospective review of patients with bone metastasis without a history of malignancy at their first visit to any clinic was undertaken using medical records and images kept at our hospitals. These patients all visited one of our university hospital departments be- The process to make a diagnosis of bone metastasis and examination to serve as the basis of suspicion or diagnosis of bone metastasis were also evaluated.
The first visit was defined as the first visit to any clinic with symptoms which were found to be due to bone metastasis in this study. The location of bone metastasis is frequently multiple; the location in this study was defined as that of the bone metastasis most related to the main symptoms at the first visit. The department at the first visit was classified as orthopedics and others. The diagnosis at the first visit was classified as bone metastasis or bone metastasis highly suspected and others; furthermore, the others were classified into some specific diagnostic categories such as degenerative spine disease, trauma, and inflammation. Bone metastasis highly sus- Number of patients with a diagnosis of "bone metastasis or bone metastasis highly suspected" at the first visit is only 6 of the 56 patients. BMS, bone metastasis or bone metastasis highly suspected; DSD, degenerated spine disease; DUS, diagnosis using symptoms such as "shoulder pain"; LBP, lower back pain. 
Results
The study population consisted of 34 men and 22 women, with a median age 69 years (range 33 90 years).
The types of primary cancers ranged widely: lung cancer in 16 patients, prostate cancer in 9, multiple myeloma in Regarding the diagnosis at the first visit, bone metastasis or bone metastasis highly suspected was made in only 6 of the 56 patients (Fig. 1) . Of the 6 patients with the diagnosis of bone metastasis or bone metastasis highly suspected at the first visit, two had a pathological fracture of a long bone, one had a compression fracture of the spine and an impending fracture of a long bone, one had an impending fracture of a long bone, one had osteoblastic change of the spine due to metastasis from the prostate gland, and the other patient had osteolytic change of a long bone due to multiple myeloma. Among other diagnoses, degenerative spine disease was the most frequent ( Fig. 1) .
FPC was seen in 35 of the 56 patients (63.5%) at diagnosis of bone metastasis (Fig. 2) . Pathological fractures were found in 53.6% of patients.
While the median POV was short (2.0 weeks), and the range was narrow (interquartile range (IQR) 1.0 to 4.0) (n =42), the median PVD was long (7.0 weeks), and the range was wide (IQR 3.0 to 14.3) (n=52) range (Fig. 3) .
Median PVS and POD were 5.5 weeks and 8.0 weeks, respectively. The median value of PVFPC was short (4.0 months), and the range was wide (IQR 0.5 to 9.0) (Fig.   4) . The median POFPC was 8.0 weeks.
Regarding the process to make a diagnosis of bone metastasis, Group C bone metastasis not diagnosed at the first visit and diagnosed only after subsequent aggravation was the most numerous (71%) (Fig. 5) . (Fig. 6) .
The most frequent examinations to serve as the basis of suspicion were X-ray (19 patients, 47.5%) and mag- Fig. 3 Periods to diagnosis of bone metastasis. The median period from the first visit to diagnosis is 7.0 weeks. POV, period from onset of symptoms to first visit; PVS, period from first visit to suspicion of bone metastasis; PVD, period from first visit to diagnosis of bone metastasis; POD, period from onset of symptoms to diagnosis of bone metastasis. Table 1) .
Discussion
In the present study, we investigated the diagnosis of bone metastasis in patients without a history of malignancy at their first visit. Our study found that such bone metastasis is extremely difficult to detect at the first visit, from unknown malignancy 6 .
We also found that FPC was associated with over half of the patients studied at the diagnosis of bone metasta- Degenerative spine disease was common as the initial diagnosis rather than bone metastasis in the present study, as well.
Another possible cause of difficulty in the diagnosis of bone metastasis from unknown malignancy is the low Table 1 Relationships between PVD and clinical factors. sensitivity of plain radiography for bone metastasis.
Negative findings of plain radiography do not always mean free-of-bone metastasis 9 . To detect apparent lytic findings of bone metastasis on plain radiographs, trabecular bone needs to be destroyed by more than half 10 . A recent study showed that each imaging modality's sensitivity and specificity for bone metastasis were respec- In Japan, no official system of general practitioners has yet been established, and thus most patients with pain in extremities or the spinal column directly visit an orthopedic practitioner in an independent clinic or a hospitalbased clinic 12 . These orthopedic practitioners usually perform a plain X-ray examination at the first visit. After the first visit, some patients continue to regularly visit the same clinic for conservative treatments such as medication, physical therapy, or nerve blocks. When bone metastasis is suspected, however, the patient is usually referred to a regional core hospital. MRI is also widely available in Japan: the number of MRI units was 51.7 per million inhabitants in 2014 in Japan, which was the largest in the world 13 .
So, what do we need for the early diagnosis of bone metastasis in patients without a history of malignancy at their first visit? Furthermore, a part of the algorithm, no improvement after 2 weeks conservative therapy, is a very subjective clinical factor, and one which is to be determined by the practitioner. Basically, in order to diagnose bone metastasis early, it is necessary to be aware of the challenges for early diagnosis and carefully take note of the transition of pain. It is difficult to diagnose bone metastasis at any stage in the absence of skeletal-related events, but it is important to diagnose it as much as possible before such events become severe. We must seriously face the important facts revealed in this research and take measures through educational activities to alert orthopedic practitioners and the medical community in general.
The present study had some limitations. First, this study was a retrospective observational study which had no control group. The aim of this study was to describe the current situation of the clinical diagnosis of bone metastasis in patients without a history of malignancy at their first visit in clinical practice. Second, our retrospective study was performed using only medical records and images kept at our hospitals, and lacking those from In conclusion, the diagnosis of bone metastasis is challenging in patients without a history of malignancy at their first visit. For early diagnosis, it is important to recognize this challenge and to keep it in mind together with ongoing observation.
